High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
暂无分享，去创建一个
J. Neal | H. Wakelee | L. Sequist | R. Heist | S. Ramalingam | A. Muzikansky | H. Husain | Helena A. Yu | J. Rotow | Z. Piotrowska | J. Bauml | J. Aredo | J. Carlisle | Jianqi Luo | A. Piper-Vallillo | Khvaramze Shaverdashvili | Deepa Rangachari | H. Yu | Jianqi Luo